Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patients.
Sabine KayserMaximilian FeszlerJulia KrzykallaMatthias SchickMichael KramerAxel BennerFelicitas TholUwe PlatzbeckerCarsten Müller-TidowAnthony D HoGerhard EhningerMichael HeuserRichard F SchlenkChristian ThiedeChristoph RölligAlwin KrämerPublished in: European journal of haematology (2017)
Our data indicate that KMT2C ELs are associated with specific genetic features and that SPRY4 ELs may add prognostic information.
Keyphrases
- acute myeloid leukemia
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- poor prognosis
- prognostic factors
- peritoneal dialysis
- genome wide
- healthcare
- big data
- gene expression
- dna methylation
- allogeneic hematopoietic stem cell transplantation
- acute lymphoblastic leukemia
- health information